π Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment β side effects, gut imbalance, or temporary Herxheimer reactions β are usually short-term and...
All content for Inside Lyme Podcast with Dr. Daniel Cameron is the property of Dr. Daniel Cameron and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
π Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment β side effects, gut imbalance, or temporary Herxheimer reactions β are usually short-term and...
In Lyme disease, hesitation can be more dangerous than treatment β the real risk is doing nothing.
Inside Lyme Podcast with Dr. Daniel Cameron
3 minutes
1 month ago
In Lyme disease, hesitation can be more dangerous than treatment β the real risk is doing nothing.
π Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment β side effects, gut imbalance, or temporary Herxheimer reactions β are usually short-term and...
Inside Lyme Podcast with Dr. Daniel Cameron
π Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment β side effects, gut imbalance, or temporary Herxheimer reactions β are usually short-term and...